REPLY
4.5.2022 09:32:07 CEST | Business Wire | Press release
Reply announced today that it has implemented a Quantum Inspired Algorithm, that can be used on both Quantum and traditional computers, for Enel , one of the leading global operators in the electricity and renewable energy production sector. The innovative solution allows Enel to quickly identify the optimal allocation of maintenance activities for operating units distributed across the areas where it operates.
For Enel, which boasts a presence in over 30 countries around the world, a network of over 2.2 million kilometres and 74 million end users, it is essential to coordinate the crews and the allocation and planning of the objectives of the operating units scattered throughout the various territories to guarantee the highest level of service for its customers. Hence the need for operational planning that is as efficient as possible.
The solution developed by Reply is based on the QUBO (Quadratic Unconstrained Binary Optimisation ) mathematical model and can be performed effectively by quantum hardware, known as Quantum Processing Units or QPUs , as well as by classical hardware, known as Graphics Processing Units or GPUs .
Extracting the maximum potential of the GPUs was possible thanks to the MegaQUBO accelerator, a software solution developed by Data Reply to speed up the implementation of Quantum Inspired Optimisation projects . MegaQUBO is a solution certified by Amazon Web Services for use on the AWS Cloud, through the “FTR - Foundational Technical Review” process, which ensures that the software adheres to AWS architectural best practices.
In addition to identifying the optimal allocation of activities, the algorithm created for Enel is also able to calculate the optimal travel routes to reach work destinations, minimising travel times and distances and maximising the time available for actual maintenance work. This leads to a significant increase in productivity and a substantial reduction in operating costs, as well as the corresponding environmental impact .
“Quantum computing makes it possible to solve challenges considered insurmountable until just a few years ago” comments Filippo Rizzante, CTO of Reply . “As we were able to successfully demonstrate based on our experience with Enel, the use of quantum algorithms to solve optimisation problems allows us to obtain significant benefits, not only in the quality of the results, but also in the reduction of processing times. At Reply, we are thus closely exploring different areas in which we can exploit the potential of quantum computing to obtain insights from extremely large and constantly updated databases.”
“The need to implement optimisation strategies on increasingly large territorial areas has correspondingly enhanced the complexity of the problem, to the point that a new and innovative approach was needed”, explains Fabio Veronese, Head of Infrastructure & Networks Digital Hub at ENEL . “The Quantum Inspired approach implemented together with Reply has made it possible to achieve significant and concrete results in the field, and is applicable to both known problems, as well as to new business contexts.”
Reply
Reply [MTA, STAR: REY, ISIN: IT0005282865] specialises in the design and implementation of solutions based on the new communication channels and digital media. Through its network of highly specialised companies, Reply partners with major European corporations in the telecoms and media, industry and services, banking and insurance, and public administration sectors, to devise and develop business models built on the new paradigms of artificial intelligence, big data, cloud computing, digital media, and the Internet of Things. Reply’s services include: Consulting, Systems Integration, and Digital Services. www.reply.com
Data Reply
Data Reply is the Reply group company that specialises in Big Data Analytics, Artificial Intelligence, and Quantum Computing. Thanks to multidisciplinary teams of specialists in Big Data Engineering, Data Science, Intelligent Process Automation, and Quantum & Accelerated Computing, Data Reply supports companies operating in different industrial sectors in their process optimisation journey, through the design and implementation of advanced Quantum Computing solutions and Machine Learning and Artificial Intelligence models. www.data.reply.com
Enel
Enel is the largest European utility by ordinary EBITDA and is present in over 30 countries worldwide, producing energy with around 88 GW of installed capacity. Enel distributes electricity through a network of over 2.2 million kilometres, and with approximately 74 million corporate and domestic end users worldwide, the Group boasts the largest customer base among European competitors. Within the Enel Group, Enel Green Power is the largest private operator in the renewable energy sector in the world, with a managed capacity of over 46 GW from wind, solar, geothermal and hydroelectric plants in Europe, the Americas, Africa, Asia and Oceania. Enel X, Enel’s global advanced energy services business line, is a world leader in demand response, with a total capacity of over 6.3 GW managed globally. The company has installed 110 MW of storage capacity and, in the electric mobility sector, over 100,000 charging points for public and private electric vehicles worldwide.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220504005064/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
